TROIKA‐1: A Double‐blind, Randomized, Parallel Group, Study Aimed to Demonstrate the Equivalent Pharmacokinetic Profile of HD201, a Potential Biosimilar Candidate to Trastuzumab, Versus EU‐Herceptin® and US‐Herceptin® in Healthy Male Subjects
Pharmacology Research & Perspectives（2021）
关键词
biosimilar,pharmacokinetic,trastuzumab
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要